These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 22738386)
1. Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history. Breitkopf CR; Sinicrope PS; Rabe KG; Brockman TA; Patten CA; McWilliams RR; Ehlers S; Petersen GM Hered Cancer Clin Pract; 2012 Jun; 10(1):8. PubMed ID: 22738386 [TBL] [Abstract][Full Text] [Related]
2. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823 [TBL] [Abstract][Full Text] [Related]
3. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of endoscopic ultrasound as a one-off pancreatic cancer screening tool for 122 high- and moderate-risk patients. Efthymiou M; Chandran S; Zorron Cheng Tao Pu L; Collins A; Rajadurai A; Nikfarjam M; Vaughan R JGH Open; 2020 Dec; 4(6):1217-1223. PubMed ID: 33319059 [TBL] [Abstract][Full Text] [Related]
5. Pancreatic Cancer Surveillance: Who, When, and How. Dudley B; Brand RE Curr Treat Options Gastroenterol; 2019 Dec; 17(4):681-691. PubMed ID: 31761968 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer screening in high-risk individuals with germline genetic mutations. DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780 [TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review. Aslanian HR; Lee JH; Canto MI Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142 [TBL] [Abstract][Full Text] [Related]
8. Screening to Detect Precursor Lesions of Pancreatic Adenocarcinoma in High-risk Individuals: A Single-center Experience. Lachter J; Rosenberg C; Hananiya T; Khamaysi I; Klein A; Yassin K; Half E Rambam Maimonides Med J; 2018 Oct; 9(4):. PubMed ID: 30309438 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the Psychosocial Impact of Pancreatic Cancer Surveillance in High-Risk Individuals. Anez-Bruzual I; Coughlin S; Clay D; Heiman J; Dungan M; Weber M; Almario CV; Leung G; Ahmad NA; Ginsberg GG; Kochman ML; Valverde KD; Long JM; Katona BW Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201514 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan. Chang MC; Wu CH; Yang SH; Liang PC; Chen BB; Jan IS; Chang YT; Jeng YM Am J Cancer Res; 2017; 7(2):357-369. PubMed ID: 28337383 [TBL] [Abstract][Full Text] [Related]
12. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program. Dwarte T; McKay S; Johns A; Tucker K; Spigelman AD; Williams D; Stoita A Hered Cancer Clin Pract; 2019; 17():30. PubMed ID: 31666883 [TBL] [Abstract][Full Text] [Related]
13. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Canto MI; Harinck F; Hruban RH; Offerhaus GJ; Poley JW; Kamel I; Nio Y; Schulick RS; Bassi C; Kluijt I; Levy MJ; Chak A; Fockens P; Goggins M; Bruno M; Gut; 2013 Mar; 62(3):339-47. PubMed ID: 23135763 [TBL] [Abstract][Full Text] [Related]
14. Receptivity and preferences of pancreatic cancer family members for participating in lifestyle programs to reduce cancer risk. Howell LA; Sinicrope PS; Brockman TA; Patten CA; Decker PA; Ehlers SL; Nadeau A; Rabe KG; Breitkopf CR; Petersen GM Hered Cancer Clin Pract; 2013 May; 11(1):3. PubMed ID: 23724897 [TBL] [Abstract][Full Text] [Related]
15. Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance. Kluijt I; Cats A; Fockens P; Nio Y; Gouma DJ; Bruno MJ J Clin Gastroenterol; 2009 Oct; 43(9):853-7. PubMed ID: 19417680 [TBL] [Abstract][Full Text] [Related]
16. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271 [TBL] [Abstract][Full Text] [Related]
17. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort. O'Neill RS; Emmanuel S; Williams D; Stoita A World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914 [TBL] [Abstract][Full Text] [Related]
18. Development of a high risk pancreatic screening clinic using 3.0 T MRI. Barnes CA; Krzywda E; Lahiff S; McDowell D; Christians KK; Knechtges P; Tolat P; Hohenwalter M; Dua K; Khan AH; Evans DB; Geurts J; Tsai S Fam Cancer; 2018 Jan; 17(1):101-111. PubMed ID: 29101607 [TBL] [Abstract][Full Text] [Related]
19. Pancreatic Cancer Screening. Das KK; Early D Curr Treat Options Gastroenterol; 2017 Dec; 15(4):562-575. PubMed ID: 28879469 [TBL] [Abstract][Full Text] [Related]